A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19

Potential treatments for coronavirus disease 2019 (COVID‐19) are being investigated at unprecedented speed, and successful treatments will rapidly be used in tens or hundreds of thousands of patients. To ensure safe and effective use in all those patents it is essential also to develop, at unprecede...

Descripción completa

Detalles Bibliográficos
Autores principales: Peck, Richard W., Weiner, Daniel, Cook, Jack, Robert Powell, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283813/
https://www.ncbi.nlm.nih.gov/pubmed/32445484
http://dx.doi.org/10.1002/cpt.1922
_version_ 1783544348729671680
author Peck, Richard W.
Weiner, Daniel
Cook, Jack
Robert Powell, J.
author_facet Peck, Richard W.
Weiner, Daniel
Cook, Jack
Robert Powell, J.
author_sort Peck, Richard W.
collection PubMed
description Potential treatments for coronavirus disease 2019 (COVID‐19) are being investigated at unprecedented speed, and successful treatments will rapidly be used in tens or hundreds of thousands of patients. To ensure safe and effective use in all those patents it is essential also to develop, at unprecedented speed, a means to provide frequently updated, optimal dosing information for all patient subgroups. Success will require immediate collaboration between drug developers, academics, and regulators.
format Online
Article
Text
id pubmed-7283813
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72838132020-06-10 A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19 Peck, Richard W. Weiner, Daniel Cook, Jack Robert Powell, J. Clin Pharmacol Ther Perspectives Potential treatments for coronavirus disease 2019 (COVID‐19) are being investigated at unprecedented speed, and successful treatments will rapidly be used in tens or hundreds of thousands of patients. To ensure safe and effective use in all those patents it is essential also to develop, at unprecedented speed, a means to provide frequently updated, optimal dosing information for all patient subgroups. Success will require immediate collaboration between drug developers, academics, and regulators. John Wiley and Sons Inc. 2020-06-29 2020-11 /pmc/articles/PMC7283813/ /pubmed/32445484 http://dx.doi.org/10.1002/cpt.1922 Text en © 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Perspectives
Peck, Richard W.
Weiner, Daniel
Cook, Jack
Robert Powell, J.
A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
title A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
title_full A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
title_fullStr A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
title_full_unstemmed A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
title_short A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
title_sort real‐world evidence framework for optimizing dosing in all patients with covid‐19
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283813/
https://www.ncbi.nlm.nih.gov/pubmed/32445484
http://dx.doi.org/10.1002/cpt.1922
work_keys_str_mv AT peckrichardw arealworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT weinerdaniel arealworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT cookjack arealworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT robertpowellj arealworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT peckrichardw realworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT weinerdaniel realworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT cookjack realworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19
AT robertpowellj realworldevidenceframeworkforoptimizingdosinginallpatientswithcovid19

Ejemplares similares